Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015–2020
Katherine R. Tuttle(Providence Regional Medical Center Everett), Meda E. Pavkov(Government of the United States of America), O. Kenrik Duru(University of California, Los Angeles), Alain K. Koyama(Centers for Disease Control and Prevention), Susanne B. Nicholas(University of California, Los Angeles), Nilka Rı́os Burrows(Centers for Disease Control and Prevention), Keith C. Norris(UCLA Health), Cami R. Jones(Providence Health & Services), Kenn B. Daratha(Providence Health & Services), Joshua J. Neumiller(Washington State University Spokane), Radica Z. Alicic(Providence Health & Services)
Cited by 101
Related Papers
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
|New England Journal of Medicine|2024|1.5k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
|American Journal of Kidney Diseases|2014|896